$57.83 0.00 (0.00%) Sarepta Therapeutics Inc - NASDAQ

Sep. 23, 2016 | 04:00 PM
Last Trade: 57.83
Trade Time: Sep 23 04:00 PM Eastern Daylight Time
Change: +0.00 (0.00%)
Prev Close: 57.83
Open: 60.51
Bid: 58.90
Ask: 59.00
  1. Biotech ETFs Lead Q3 Rally: XBI Breaks Out

    TalkMarkets | Sep. 22, 2016 | 21:00PM EST
  2. Sarepta Stock Slides As FDA Sends Another Bad Signal On DMD

    IBD | Jul. 14, 2016 | 11:13AM EST
  3. Sarepta Says FDA Postpones Advisory Committee Meeting to Review Eteplirsen Due to Severe Weather Storm in the Washington D.C.

    Benzinga | Jan. 20, 2016 | 19:44PM EST
  4. Benzinga's Top Downgrades

    Benzinga | Jan. 19, 2016 | 09:30AM EST
  5. Sarepta drops on FDA release

    IBD | Jan. 15, 2016 | 18:43PM EST
  6. Sarepta Plummets As FDA Slams Muscular Dystrophy Drug

    IBD | Jan. 15, 2016 | 12:53PM EST
  7. BioMarin Muscular Dystrophy Drug Rejected By FDA

    IBD | Jan. 14, 2016 | 12:29PM EST
  8. FDA Panel Seen As Bad For BioMarin, Good For Sarepta

    IBD | Nov. 25, 2015 | 14:34PM EST
  9. BioMarin Drug's Future In Doubt After FDA Panel Vote

    IBD | Nov. 24, 2015 | 18:41PM EST
  10. KaloBios, Valeant Lead Week's 5 Top Drug Stock Gainers

    IBD | Nov. 21, 2015 | 08:15AM EST
  11. Benzinga's Top Initiations

    Benzinga | Oct. 23, 2015 | 08:20AM EST
  12. PTC Stock Seesaws On Muscular Dystrophy Drug Data

    IBD | Oct. 15, 2015 | 18:54PM EST
  13. Sarepta Therapeutics Inc. Not Giving Back Gains

    Benzinga | Oct. 1, 2015 | 11:26AM EST
  14. Sarepta Stock Soars On New Muscular-Dystrophy Data

    IBD | Oct. 1, 2015 | 11:19AM EST
  15. Benzinga's Volume Movers

    Benzinga | Oct. 1, 2015 | 10:36AM EST
Trading Center